Melissa Johnston
Payments from drug & device makers
Across 252 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$899
- Teva Pharmaceuticals USA, Inc.$393
- Otsuka America Pharmaceutical, Inc.$390
- Lundbeck LLC$360
- Neurocrine Biosciences, Inc.$304
- GSK$302
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,552100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 70 | $899 |
| Teva Pharmaceuticals USA, Inc. | 20 | $393 |
| Otsuka America Pharmaceutical, Inc. | 23 | $390 |
| Lundbeck LLC | 22 | $360 |
| Neurocrine Biosciences, Inc. | 17 | $304 |
| GSK | 14 | $302 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $292 |
| Indivior Inc. | 12 | $236 |
| Vanda Pharmaceuticals Inc. | 9 | $223 |
| AstraZeneca | 5 | $207 |
| Gilead | 9 | $152 |
| Axsome Therapeutics, Inc. | 7 | $129 |
| Esperion Therapeutics, Inc. | 1 | $125 |
| Alkermes, Inc. | 5 | $98 |
| Lilly USA, LLC | 5 | $84 |
| Idorsia Pharmaceuticals US Inc | 4 | $67 |
| Johnson & Johnson(2 entities) | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Eisai Inc. | 3 | $44 |
| Tris Pharma Inc | 2 | $36 |
| Novo Nordisk | 2 | $34 |
| Abbott | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Corium, LLC | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,552 in reported general payments places this provider in the 90th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 47 | $52,012 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 66 | $48,871 |
| FarxigaDapagliflozin Propanediol | 32 | $32,276 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 16 | $10,272 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $1,614 |
| Gabapentin | 83 | $1,305 |
| Doxycycline Monohydrate | 25 | $1,261 |
| Pregabalin | 20 | $1,101 |
| Ventolin HfaAlbuterol Sulfate | 17 | $956 |
| Duloxetine Hcl | 60 | $805 |
| SynthroidLevothyroxine Sodium | 13 | $598 |
| Omeprazole | 51 | $556 |
| Prazosin Hcl | 14 | $427 |
| ValacyclovirValacyclovir Hcl | 15 | $423 |
| Dicyclomine Hcl | 17 | $420 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $302 | $59,14382 claims |
| Novo NordiskOzempic | $34 | $52,01247 claims |
| AstraZenecaFarxiga | $207 | $32,27632 claims |
| AbbVieSynthroid | $899 | $59813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,392 family providers in Indiana.
Other family in Salem
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.